Disruption of 3CLpro protease self-association by short peptides as a potential route to broad spectrum coronavirus inhibitors

References

• Agrawal, P., Singh, H., Srivastava, H. K., Singh, S., Kishore, G., & Raghava, G. P. S. (2019). Benchmarking of different molecular docking methods for protein-peptide docking. BMC Bioinformatics, 19(S13),105-124 .https://doi.org/10.1186/s12859-018-2449-y
   Google Scholar
• Alamri, M. A., Tahir Ul Qamar, M., Mirza, M. U., Bhadane, R., Alqahtani, S. M., Muneer, I., Froeyen, M., & Salo-Ahen, O. M. H. (2020). Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL(pro). Journal of Biomolecular Structure and Dynamics, 39(13), 4936–4948.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014). Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: An observational study. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 20, 42–46.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq, J. A., Zumla, A., & Memish, Z. A. (2014). Coronaviruses: Severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Current Opinion in Infectious Diseases, 27(5), 411–417.
   PubMed Web of Science ®Google Scholar
• Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J., & Hilgenfeld, R. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. The EMBO Journal, 21(13), 3213–3224. https://doi.org/10.1093/emboj/cdf327
   PubMed Web of Science ®Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.), 300(5626), 1763–1767. https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Arkin, M. R., & Wells, J. A. (2004). Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream. Nature Reviews Drug Discovery, 3(4), 301–317. https://doi.org/10.1038/nrd1343
   PubMed Web of Science ®Google Scholar
• Baranov, P. V., Henderson, C. M., Anderson, C. B., Gesteland, R. F., Atkins, J. F., & Howard, M. T. (2005). Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology, 332(2), 498–510. https://doi.org/10.1016/j.virol.2004.11.038
   PubMed Web of Science ®Google Scholar
• Barnard, D. L., & Kumaki, Y. (2011). Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy. Future Virology, 6(5), 615–631. https://doi.org/10.2217/fvl.11.33
   PubMed Web of Science ®Google Scholar
• Bogan, A. A., & Thorn, K. S. (1998). Anatomy of hot spots in protein interfaces. Journal of Molecular Biology, 280(1), 1–9.
   PubMed Web of Science ®Google Scholar
• Chen, S., Zhang, J., Hu, T., Chen, K., Jiang, H., & Shen, X. (2008). Residues on the dimer interface of SARS coronavirus 3C-like protease: Dimer stability characterization and enzyme catalytic activity analysis. Journal of Biochemistry, 143(4), 525–536. https://doi.org/10.1093/jb/mvm246
   PubMed Web of Science ®Google Scholar
• Chiou, H.-E., Liu, C.-L., Buttrey, M. J., Kuo, H.-P., Liu, H.-W., Kuo, H.-T., & Lu, Y.-T. (2005). Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: Experience in two medical centers. Chest, 128(1), 263–272. https://doi.org/10.1378/chest.128.1.263
   PubMed Web of Science ®Google Scholar
• Ciccotti, G., & Ryckaert, J. P. (1986). Molecular dynamics simulation of rigid molecules. Computer Physics Reports, 4(6), 346–392. https://doi.org/10.1016/0167-7977(86)90022-5
   Google Scholar
• Czodrowski, P., Dramburg, I., Sotriffer, C. A., & Klebe, G. (2006). Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein–ligand complexes. Proteins: Structure, Function, and Bioinformatics, 65(2), 424–437. https://doi.org/10.1002/prot.21110
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., & Baker, N. A. (2007). PDB2PQR: Expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Research, 35(suppl_2), W522–W525.
   PubMedGoogle Scholar
• Dong, N., Yang, X., Kaichao, C., Chan, E., Yang, M., & Chen, S. (2020). Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China.
   Google Scholar
• ElSawy, K. M., Lane, D. P., Verma, C. S., & Caves, L. S. D. (2016). Recognition dynamics of p53 and MDM2: Implications for peptide design. The Journal of Physical Chemistry B, 120(2), 320–328. https://doi.org/10.1021/acs.jpcb.5b11162
   PubMed Web of Science ®Google Scholar
• ElSawy, K. M., Twarock, R., Verma, C. S., & Caves, L. S. D. (2012). Peptide inhibitors of viral assembly: A novel route to broad-spectrum antivirals. Journal of Chemical Information and Modeling, 52(3), 770–776. https://doi.org/10.1021/ci200467s
   PubMed Web of Science ®Google Scholar
• ElSawy, K. M., Verma, C. S., Joseph, T. L., Lane, D. P., Twarock, R., & Caves, L. S. (2013). On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: A Brownian dynamics study. Cell Cycle (Georgetown, Tex.), 12(3), 394–404. https://doi.org/10.4161/cc.23511
   PubMed Web of Science ®Google Scholar
• Fan, Y., Zhao, K., Shi, Z.-L., & Zhou, P. (2019). Bat Coronaviruses in China. Viruses, 11(3), 210. https://doi.org/10.3390/v11030210
   PubMed Web of Science ®Google Scholar
• FDA Remdesivir EUA: letter of authorization. https://www.fda.gov/media/137564/download
   Google Scholar
• Fox, J. L. (2007). Antivirals become a broader enterprise. Nature Biotechnology, 25(12), 1395–1402.
   PubMed Web of Science ®Google Scholar
• Garrett, M. M., David, S. G., Robert, S. H., Ruth, H., William, E. H., Richard, K. B., & Arthur, J. O. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662.
   Web of Science ®Google Scholar
• Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., & Martinez, A. (2020). COVID-19: Drug targets and potential treatments. Journal of Medicinal Chemistry, 63(21), 12359–12386.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Ruiz, D., & Gohlke, H. (2006). Targeting protein-protein interactions with small molecules: Challenges and perspectives for computational binding epitope detection and ligand finding. Current Medicinal Chemistry, 13(22), 2607–2625.
   PubMed Web of Science ®Google Scholar
• Grum-Tokars, V., Ratia, K., Begaye, A., Baker, S. C., & Mesecar, A. D. (2008). Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery. Virus Research, 133(1), 63–73.
   PubMed Web of Science ®Google Scholar
• Hauser, A. S., & Windshügel, B. (2016). LEADS-PEP: A benchmark data set for assessment of peptide docking performance. Journal of Chemical Information and Modeling, 56(1), 188–200.
   PubMed Web of Science ®Google Scholar
• Herschlag, D., & Pinney, M. M. (2018). Hydrogen bonds: Simple after all? Biochemistry, 57(24), 3338–3352. https://doi.org/10.1021/acs.biochem.8b00217
   PubMed Web of Science ®Google Scholar
• Hetenyi, C., & van der Spoel, D. (2002). Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Science : A Publication of the Protein Society, 11(7), 1729–1737.
   PubMed Web of Science ®Google Scholar
• Hetényi, C., & van der Spoel, D. (2006). Blind docking of drug-sized compounds to proteins with up to a thousand residues. FEBS Letters, 580(5), 1447–1450.
   PubMed Web of Science ®Google Scholar
• Hwang, H., Dey, F., Petrey, D., & Honig, B. (2017). Structure-based prediction of ligand-protein interactions on a genome-wide scale. Proceedings of the National Academy of Sciences of the United States of America, 114(52), 13685–13690. https://doi.org/10.1073/pnas.1705381114
   PubMed Web of Science ®Google Scholar
• James, C. P., Rosemary, B., Wei, W., James, G., Emad, T., Elizabeth, V., Christophe, C., Robert, D. S., Laxmikant, K., & Klaus, S. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26, 1781–1802.
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Madura, J. D., & Swenson, C. J. (1984). Optimized intermolecular potential functions for liquid hydrocarbons. Journal of the American Chemical Society, 106(22), 6638–6646. [Database] https://doi.org/10.1021/ja00334a030
   Web of Science ®Google Scholar
• Lai, L., Han, X., Chen, H., Wei, P., Huang, C., Liu, S., Fan, K., Zhou, L., Liu, Z., Pei, J., & Liu, Y. (2006). Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase. Current Pharmaceutical Design, 12(35), 4555–4564.
   PubMed Web of Science ®Google Scholar
• Liu, W. S., Li, H. G., Ding, C. H., Zhang, H. X., Wang, R. R., & Li, J. Q. (2021). Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation . Aging, 13(5), 6258–6272. https://doi.org/10.18632/aging.202703
   PubMedGoogle Scholar
• Liu, W., Morse, J. S., Lalonde, T., & Xu, S. (2020). Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV. ChemBioChem.
   Web of Science ®Google Scholar
• MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., Joseph-McCarthy, D., Kuchnir, L., Kuczera, K., Lau, F. T. K., Mattos, C., Michnick, S., Ngo, T., Nguyen, D. T., Prodhom, B., … Karplus, M. (1998). All-atom empirical potential for molecular modeling and dynamics studies of proteins. The Journal of Physical Chemistry B, 102(18), 3586–3616. https://doi.org/10.1021/jp973084f
   PubMed Web of Science ®Google Scholar
• Mackerell, A. D., Jr.; Feig, M., & Brooks, C. L. (2004). Extending the treatment of backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. Journal of Computational Chemistry, 25(11), 1400–1415. [Database] https://doi.org/10.1002/jcc.20065
   PubMed Web of Science ®Google Scholar
• Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007). Hot spots—A review of the protein–protein interface determinant amino-acid residues. Proteins: Structure, Function, and Bioinformatics, 68(4), 803–812. https://doi.org/10.1002/prot.21396
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
   PubMed Web of Science ®Google Scholar
• Muller, M. P., Dresser, L., Raboud, J., McGeer, A., Rea, E., Richardson, S. E., Mazzulli, T., Loeb, M., & Louie, M. (2007). Adverse events associated with high‐dose ribavirin: Evidence from the toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy, 27(4), 494–503. https://doi.org/10.1592/phco.27.4.494
   PubMed Web of Science ®Google Scholar
• Nguyen, N. T., Nguyen, T. H., Pham, T. N. H., Huy, N. T., Bay, M. V., Pham, M. Q., Nam, P. C., Vu, V. V., & Ngo, S. T. (2020). Autodock vina adopts more accurate binding poses but autodock4 forms better binding affinity. Journal of Chemical Information and Modeling, 60(1), 204–211. https://doi.org/10.1021/acs.jcim.9b00778
   PubMed Web of Science ®Google Scholar
• Shamsi, A., Mohammad, T., Anwar, S., AlAjmi, M. F., Hussain, A., Rehman, M. T., Islam, A., & Hassan, M. I. (2020). Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible implication in COVID-19 therapy. Bioscience Reports, 40.
   PubMed Web of Science ®Google Scholar
• Shamsi, A., Mohammad, T., Anwar, S., Amani, S., Khan, M. S., Husain, F. M., Rehman, M. T., Islam, A., & Hassan, M. I. (2021). Potential drug targets of SARS-CoV-2: From genomics to therapeutics. International Journal of Biological Macromolecules, 177, 1–9.
   PubMed Web of Science ®Google Scholar
• Shi, J., Sivaraman, J., & Song, J. (2008). Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease. Journal of Virology, 82(9), 4620–4629.
   PubMed Web of Science ®Google Scholar
• Siemieniuk, R., Rochwerg, B., Agoritsas, T., Lamontagne, F., Leo, Y. S., Macdonald, H., Agarwal, A., Zeng, L., Lytvyn, L., Appiah, J. A., & Amin, W. (2020). A living WHO guideline on drugs for Covid-19. Bmj, 371, m4475. https://doi.org/10.1136/bmj.m4475
   PubMedGoogle Scholar
• Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019). From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1), 59. https://doi.org/10.3390/v11010059
   PubMed Web of Science ®Google Scholar
• Tan, J., Verschueren, K. H. G., Anand, K., Shen, J., Yang, M., Xu, Y., Rao, Z., Bigalke, J., Heisen, B., Mesters, J. R., Chen, K., Shen, X., Jiang, H., & Hilgenfeld, R. (2005). pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: Molecular dynamics simulations and multiple X-ray structure analyses. Journal of Molecular Biology, 354(1), 25–40. https://doi.org/10.1016/j.jmb.2005.09.012
   PubMed Web of Science ®Google Scholar
• Team, R. C. (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing.
   Google Scholar
• Tuncbag, N., Gursoy, A., & Keskin, O. (2009). Identification of computational hot spots in protein interfaces: Combining solvent accessibility and inter-residue potentials improves the accuracy. Bioinformatics (Oxford, England), 25(12), 1513–1520. https://doi.org/10.1093/bioinformatics/btp240
   PubMed Web of Science ®Google Scholar
• Tuncbag, N., Keskin, O., & Gursoy, A. (2010). HotPoint: Hot spot prediction server for protein interfaces. Nucleic Acids Research, 38(suppl_2), W402–406.
   PubMedGoogle Scholar
• Verlet, L. (1967). Computer "experiments" on classical fluids. I. Thermodynamical properties of Lennard-Jones molecules. Physical Review, 159(1), 98–103. https://doi.org/10.1103/PhysRev.159.98
   Web of Science ®Google Scholar
• Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. The Lancet), 395(10223), 470–473. https://doi.org/10.1016/S0140-6736(20)30185-9
   PubMed Web of Science ®Google Scholar
• Wang, Q., Zhao, Y., Chen, X., & Hong, A. (2020). Virtual screening of approved clinic drugs with main protease (3CL(pro)) reveals potential inhibitory effects on SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1817786
   Google Scholar
• WHO Coronavirus disease (COVID-19) dashboard. https://covid19.who.int/
   Google Scholar
• WHO Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
   Google Scholar
• WHO recommends against the use of remdesivir in COVID-19 patients. https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
   Google Scholar
• Wójcik, P., & Berlicki, Ł. (2016). Peptide-based inhibitors of protein–protein interactions. Bioorganic & Medicinal Chemistry Letters, 26(3), 707–713.
   PubMed Web of Science ®Google Scholar
• Woo, P. C., Huang, Y., Lau, S. K., & Yuen, K.-Y. (2010). Coronavirus genomics and bioinformatics analysis. Viruses, 2(8), 1804–1820. https://doi.org/10.3390/v2081803
   PubMed Web of Science ®Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., & Pei, Y.-Y. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269.
   Web of Science ®Google Scholar
• Xia, B., & Kang, X. (2011). Activation and maturation of SARS-CoV main protease. Protein & Cell, 2(4), 282–290. https://doi.org/10.1007/s13238-011-1034-1
   PubMed Web of Science ®Google Scholar
• Xu, X., Liu, Y., Weiss, S., Arnold, E., Sarafianos, S. G., & Ding, J. (2003). Molecular model of SARS coronavirus polymerase: Implications for biochemical functions and drug design. Nucleic Acids Research, 31(24), 7117–7130.
   PubMed Web of Science ®Google Scholar
• Yang, H., Bartlam, M., & Rao, Z. (2006). Drug design targeting the main protease, the Achilles' heel of coronaviruses. Current Pharmaceutical Design, 12(35), 4573–4590.
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Zehra, Z., Luthra, M., Siddiqui, S. M., Shamsi, A., Gaur, N. A., & Islam, A. (2020). Corona virus versus existence of human on the earth: A computational and biophysical approach. International Journal of Biological Macromolecules, 161, 271–281.
   PubMed Web of Science ®Google Scholar
• Zhang, W., Bell, E. W., Yin, M., & Zhang, Y. (2020). EDock: Blind protein-ligand docking by replica-exchange Monte Carlo simulation . Journal of Cheminformatics, 12(1), 37. https://doi.org/10.1186/s13321-020-00440-9
   PubMed Web of Science ®Google Scholar
• Zhang, Y., & Sanner, M. F. (2019). AutoDock CrankPep: Combining folding and docking to predict protein-peptide complexes. Bioinformatics (Oxford, England), 35(24), 5121–5127. https://doi.org/10.1093/bioinformatics/btz459
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., & Huang, C.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270–273.
   Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., & Lu, R. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382, 727-33.
   Google Scholar
• Ziebuhr, J., Snijder, E. J., & Gorbalenya, A. E. (2000). Virus-encoded proteinases and proteolytic processing in the Nidovirales. The Journal of General Virology, 81(Pt 4), 853–879.
   PubMed Web of Science ®Google Scholar